During the EMT process, tumor cells also acquire progenitor/stem cells (CSC) marker expression (e.g., CD44, CD133, Nanog, and OCT-4) and properties, notably self-renewal, asymmetric cell division, tumor initiation, drug resistance, and disease recurrence. Here, NANOG is linked to neoplasm.